Cargando…
Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy
Inherited retinal diseases (IRDs) are a leading cause of blindness in industrialized countries, and gene therapy is quickly becoming a viable option to treat this group of diseases. Gene replacement using a viral vector has been successfully applied and advanced to commercial use for a rare group of...
Autores principales: | Ren, Duohao, Fisson, Sylvain, Dalkara, Deniz, Ail, Divya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502120/ https://www.ncbi.nlm.nih.gov/pubmed/36145721 http://dx.doi.org/10.3390/pharmaceutics14091973 |
Ejemplares similares
-
Systemic and local immune responses to intraocular AAV vector administration in non-human primates
por: Ail, Divya, et al.
Publicado: (2022) -
Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
por: Ail, Divya, et al.
Publicado: (2023) -
New Editing Tools for Gene Therapy in Inherited Retinal Dystrophies
por: Pulman, Juliette, et al.
Publicado: (2022) -
Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
por: Caffery, Breanne, et al.
Publicado: (2019) -
Technique of retinal gene therapy: delivery of viral vector into the subretinal space
por: Xue, K, et al.
Publicado: (2017)